0001209191-16-092753.txt : 20160120 0001209191-16-092753.hdr.sgml : 20160120 20160120201231 ACCESSION NUMBER: 0001209191-16-092753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160115 FILED AS OF DATE: 20160120 DATE AS OF CHANGE: 20160120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANAYA SUSAN M CENTRAL INDEX KEY: 0001226064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 161352263 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-15 0 0001340652 ChemoCentryx, Inc. CCXI 0001226064 KANAYA SUSAN M C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 SVP, Finance, CFO and Sec. Common Stock 2016-01-15 4 M 0 300 2.00 A 300 D Common Stock 2016-01-15 4 S 0 300 4.00 D 0 D Common Stock 2016-01-19 4 M 0 6134 2.00 A 6134 D Common Stock 2016-01-19 4 S 0 6134 4.0472 D 0 D Common Stock 2016-01-20 4 M 0 14971 2.00 A 14971 D Common Stock 2016-01-20 4 S 0 14971 4.0973 D 0 D Stock Option (right to buy) 2.00 2016-01-15 4 M 0 300 D 2006-02-09 2016-02-09 Common Stock 300 46869 D Stock Option (right to buy) 2.00 2016-01-19 4 M 0 6134 D 2006-02-09 2016-02-09 Common Stock 6134 40735 D Stock Option (right to buy) 2.00 2016-01-20 4 M 0 14971 D 2006-02-09 2016-02-09 Common Stock 14971 25764 D The sales reported in this Form 4 were effected pursuant to a December 2014 Rule 10b5-1 trading plan adopted by the Reporting Person. Shares sold are associated with stock options which will expire in February 2016. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.00 to $4.16 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.00 to $4.22 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. As of January 15, 2016 and prior to this transaction, the option fully vested. Not applicable. /s/ Susan M. Kanaya 2016-01-20